Indication

Complement component 3 glomerulopathy

Complement component 3 glomerulopathy (C3G) is a rare, complement-mediated renal disorder affecting the glomeruli across pediatric and adult populations. Read more about Complement component 3 glomerulopathy

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Complement component 3 glomerulopathy therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Complement component 3 glomerulopathy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Complement component 3 glomerulopathy.

Complement component 3 glomerulopathy (C3G) is a rare, complement-mediated renal disorder affecting the glomeruli across pediatric and adult populations.

It is caused by acquired or genetic dysregulation of the alternative complement pathway, resulting in excessive complement activation in the circulation and within the glomerular microenvironment.

Pathophysiologically, the disease is defined on renal biopsy by prominent, dominant deposition of complement component 3 (C3) with absent or minimal immunoglobulin staining, comprising two major histological subtypes: C3 glomerulonephritis and dense deposit disease.

Clinically, affected patients typically present with hematuria, proteinuria, nephritic or nephrotic syndrome, and progressive decline in kidney function that frequently advances to end-stage renal disease.

Personalize your experience

Follow Complement component 3 glomerulopathy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it